ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0418

Improving Documentation of Contraception and Pregnancy Intention in Rheumatology Practice

Megan Clowse1, Puneet Bajaj2, Bonnie Bermas2, Julie Chiesa3, Kathryn Dao4, Pamela Freeman5, Bansari Gujar6, Brittany Hill7, Kelley Jones8, Richard Jones9, Ann Marslett10, Brooke Mills11, James Roberts2, Amanda Snyderman8 and Leah Zulig12, 1Duke University, Chapel Hill, NC, 2UT Southwestern Medical Center, Dallas, TX, 3InfoDirectors, Durham, NC, 4Rheum101, Rockville, MD, 5Rheumatology Associates of Central Florida, Orlando, FL, 6Rheumatology Associates of Baltimore, Towson, MD, 7Clinic for Rheumatic Disease, Tuscaloosa, AL, 8Duke University School of Medicine, Durham, 9Clinic for Rheumatic Diseases, Northport, AL, 10Rheumatology Associates of Baltimore, Baltimore, MD, 11UT Southwestern Medical Center, Fort Worth, TX, 12Duke University School of Medicine, Durham, NC

Meeting: ACR Convergence 2024

Keywords: pregnancy, Quality Indicators, Women's health

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: Reproductive Issues in Rheumatic Disorders Poster

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Prior studies of RISE Registry found 9-11% of women of reproductive age with contraception documentation.  We sought to identify and assess methods to increase contraception documentation within RISE Registry sites. 

Methods: We used a Learning Collaborative (LC) model to bring together experts and clinical rheumatologists from RISE Registry clinics every 4-8 weeks for 2 years.  The LC determined a quality measure and data they considered both clinically important and feasible to collect, as well as data collection and reporting methods.  Data from community clinics (Sites A, B, C) was extracted via EMR reporting of individual patients; academic centers (Sites D, E) reported aggregate data for up to 30 patients per month. Data are presented in run charts with the overall mean and 3 standard deviations (SD). Consecutive rates more than 3 SD from the mean indicate a statistically significant pattern change.  

Results: Providers from 7 clinics joined the LC and 5 clinics actively participated and provided data. The LC defined the quality metric: Among individuals of reproductive potential ages 15 to 44, the percentage that had documentation of contraceptive use, non-use, or infecundity. The LC also elected to document interest in pregnancy and to complete these data for all females of reproductive age at every visit.

Documentation location: All sites originally had a carried-forward patient-specific data-field for contraception and most did not use this field. None had a pregnancy intention data field. The LC determined that flagged, easy-to-access, visit-specific data-fields would facilitate data collection; these were created within the community practice EMRs. Academic sites put a dotphrase into note templates. 

Method of documentation: Sites A and B elected to have medical assistants ask and document the data during check-in.  Site C, D, and E elected to have the providers ask and document during the encounter.

Improving documentation: Once the custom fields were in place, Sites A & B had rapid uptake of contraception documentation (Figure 1) and pregnancy interest with significant improvement over the next 5 months. At Site C, 2 providers had significant improvements over time; the remaining providers only had a modest increase with the custom field. Site D had high use of the contraception dotphrase throughout.  Site E had moderate levels of documentation that did not increase.

Patient responses: Among the 1057 women with documentation of pregnancy intention, 7.6% reported that ‘yes,’ they were interested in pregnancy in the next year, while 2.7% were either ‘unsure’ or ‘OK either way.’ Within a six-month period, of the 109 who reported yes, unsure, or OK either way, 13% had a change in their response.

Conclusion: Routinely documenting contraception and pregnancy interest is feasible in academic and community rheumatology practices. Documentation is enhanced by well-placed, flagged, visit-specific data fields and completion by medical assistants or very engaged providers.  An estimated 10% of women with rheumatic disease of reproductive age are interested in pregnancy, a state that can change over the course of 6 months. 

Supporting image 1

Contraception documentation over time at each site.


Disclosures: M. Clowse: AstraZeneca, 2, GlaxoSmithKlein(GSK), 2, 5, UCB, 2, 5; P. Bajaj: None; B. Bermas: None; J. Chiesa: None; K. Dao: Aurinia Pharmaceuticals, 2, 3, Bristol-Myers Squibb(BMS), 1, Novartis, 1; P. Freeman: None; B. Gujar: None; B. Hill: None; K. Jones: None; R. Jones: None; A. Marslett: None; B. Mills: None; J. Roberts: None; A. Snyderman: GlaxoSmithKlein(GSK), 5; L. Zulig: None.

To cite this abstract in AMA style:

Clowse M, Bajaj P, Bermas B, Chiesa J, Dao K, Freeman P, Gujar B, Hill B, Jones K, Jones R, Marslett A, Mills B, Roberts J, Snyderman A, Zulig L. Improving Documentation of Contraception and Pregnancy Intention in Rheumatology Practice [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/improving-documentation-of-contraception-and-pregnancy-intention-in-rheumatology-practice/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/improving-documentation-of-contraception-and-pregnancy-intention-in-rheumatology-practice/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology